History Of Soviet Adaptogen Research

Last updated: October 4, 2026 - Reviewed by Verdant Wellness Editorial Team

RD

By Gabriela Mitchell, Registered Dietitian (Linkedin)

Last Updated August 2026  ·  35 min read

10% off · weekly tips

Real science on cortisol, stress, and sleep.

Send it →

---

Table of Contents

• What Is an Adaptogen? The Soviet Definition Explained
• The Origins: Nikolai Lazarev and the Birth of Adaptogen Science
• Israel Brekhman and the Formalization of Adaptogen Research
• The Key Plants: Which Herbs Did Soviet Scientists Study?
• Soviet Military and Defense Applications of Adaptogens
• Athletes, Cosmonauts, and Cold War Performance Enhancement
• How Much Evidence Actually Existed? The Soviet Clinical Record
• Criticisms and Limitations of Soviet Adaptogen Research
• From Soviet Laboratories to Western Markets: The Transition
• What Soviet-Era Findings Still Hold Up Today?
• The Difference Between Soviet Science and Modern Supplement Marketing
• Frequently Asked Questions
• Conclusion

---

Introduction

If you have ever reached for an ashwagandha capsule, sipped a Rhodiola tea, or added Eleuthero to your morning smoothie, you are participating in a tradition that began in the laboratories and military research stations of the Soviet Union more than seventy years ago. The history of Soviet adaptogen research is one of the most fascinating chapters in twentieth-century pharmacology — a story of wartime urgency, Cold War secrecy, remarkable scientific ambition, and a body of clinical evidence that the Western world largely ignored for decades before suddenly embracing it wholesale.

This is not a simple story of fringe pseudoscience or straightforward mainstream validation. The history of Soviet adaptogen research sits in complicated territory: real scientists conducting real experiments under enormous institutional pressure, studying real plants with genuine biological activity, but operating within a system that made independent verification difficult and ideological influence on science almost inevitable.

Understanding where adaptogens came from — who defined them, who tested them, why governments funded the research, and how reliable that research actually was — is essential for anyone who wants to think clearly about these substances today. The adaptogen history is, in many ways, the hidden backstory of the modern wellness industry.

This post covers everything: the founding scientists, the defining experiments, the military programs, the clinical evidence base, the criticisms, and the questions that remain unanswered today.

---

★★★★★ 4.8 · 1,247 reviews

Feel Calm By Bedtime. Focused By Morning.

Adaptogen-based formula. Third-party tested. Made in an FDA-registered facility. Backed by a 60-day money-back guarantee.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

What Is an Adaptogen? The Soviet Definition Explained

Before diving into the history, it helps to understand exactly what Soviet scientists meant when they used the word "adaptogen," because the original definition was considerably more precise than what the term has come to mean in contemporary wellness marketing.

The concept emerged from a specific scientific tradition: the study of substances that could help living organisms resist stress — not just psychological stress in the modern sense, but physiological stress in the broadest possible meaning. Starvation. Extreme cold. Extreme heat. Physical exhaustion. Toxic exposure. Infectious disease. Radiation. The Soviet scientists were interested in what they called "nonspecific resistance" — the ability of an organism to withstand a wide variety of harmful influences, not just one specific threat.

The formal adaptogen definition in the Soviet scientific tradition required three criteria. First, the substance had to be essentially nontoxic, causing minimal disturbance to normal physiological function. Second, it had to increase nonspecific resistance to a broad range of physical, chemical, and biological stressors. Third, it had to normalize physiological parameters regardless of the direction of the pathological change — meaning it would raise what was too low and lower what was too high, acting as a biological regulator rather than a simple stimulant or suppressant.

That third criterion is particularly important and is often overlooked in popular discussions. The Soviet definition was not describing a stimulant. It was not describing something that simply boosted energy or enhanced performance in a straightforward, dose-dependent way. It was describing something that acted as an adaptive regulator — bringing the organism back toward homeostasis under conditions of stress.

This is a genuinely interesting pharmacological concept, and the fact that it originated in Soviet military research rather than academic pharmacology gives it an unusual character. The definition was shaped by practical military and industrial needs rather than pure scientific curiosity. That context shaped everything that followed.

The Origins: Nikolai Lazarev and the Birth of Adaptogen Science

The adaptogen discovery story begins with a Soviet pharmacologist named Nikolai Vasilyevich Lazarev. Born in 1895, Lazarev was a prominent figure in Soviet toxicology and pharmacology who spent much of his career studying how various substances affected the body's capacity to resist stress and disease. He was the director of the Leningrad Institute of Labor Hygiene and Occupational Diseases for many years and was deeply interested in what he called "the state of nonspecific increased resistance" — SNIR in the Soviet literature.

Lazarev introduced the term "adaptogen" in 1958, using it to describe pharmacological agents that could induce this state of nonspecific resistance. According to the historical record, his work was partly inspired by observations made during and after World War II about how certain natural substances seemed to help workers and soldiers maintain performance under extremely difficult conditions.

The timing of Lazarev's formal definition — 1958 — is significant. This was the height of the Cold War, the year of the first Soviet lunar probe, and a period of intense Soviet investment in human performance research. The Soviet state was deeply interested in any scientific avenue that might produce stronger soldiers, more resilient workers, and better-performing athletes. Lazarev's concept of the adaptogen fit perfectly into this ideological and practical framework.

What Lazarev actually proposed was not entirely unprecedented. The idea that certain natural substances could broadly enhance an organism's resilience had roots in traditional Chinese medicine and indigenous Siberian healing practices — many of the plants that would later become the primary Soviet adaptogens had been used by indigenous Siberian peoples for generations. What Lazarev did was attempt to create a rigorous pharmacological framework for studying and defining this effect scientifically.

His early work focused on synthetic compounds as much as natural ones. But the direction of Soviet adaptogen science history would be definitively shaped toward natural plant substances by the work of the scientist who became his most important student and collaborator.

Israel Brekhman and the Formalization of Adaptogen Research

If Lazarev invented the concept, Israel Brekhman built the science. Brekhman is unquestionably the central figure in Soviet adaptogen research, and his work over more than four decades represents the most substantial single contribution to the adaptogen research history of the twentieth century.

Israel Ilyich Brekhman was born in 1921 and spent much of his scientific career at the Institute of Biologically Active Substances in Vladivostok — an institute that was itself created partly to pursue adaptogen research in the Soviet Far East, where many of the key adaptogenic plants grew wild. The geographical context is important: Vladivostok sits at the edge of the Ussuri taiga, one of the most biodiverse temperate forests in the world, and a region with deep traditions of medicinal plant use.

Brekhman's most famous contribution to adaptogen development was his work on Eleutherococcus senticosus, also known as Siberian ginseng — a plant that would become the signature Soviet adaptogen and the primary subject of decades of clinical investigation. Brekhman recognized that Panax ginseng, the "true" ginseng of Chinese medicine, was expensive, difficult to cultivate in large quantities, and not widely available in the Soviet Far East. He began investigating Eleutherococcus as a potentially cheaper, more abundant alternative.

What he found convinced him that Eleutherococcus was not merely a ginseng substitute but a genuinely remarkable plant with broad pharmacological activity. His research documented effects on exercise capacity, cognitive performance, immune function, and stress resistance in both animal models and human subjects. By the early 1960s, Brekhman had become the leading voice in Soviet pharmacology arguing for the development of Eleutherococcus as a medicinal substance.

The Brekhman adaptogen framework became the definitive scientific standard for the field. He refined Lazarev's original definition, articulated the three-criteria model that would become canonical, and supervised or inspired dozens of studies across Soviet research institutions. His 1968 monograph on Eleutherococcus became one of the foundational texts of adaptogen history, summarizing years of experimental and clinical work.

Perhaps most importantly for the long-term development of the field, Brekhman and his colleague I.V. Dardymov published a 1969 paper in the Western pharmacological journal Annual Review of Pharmacology that introduced the adaptogen concept to an English-speaking scientific audience for the first time. This paper was a deliberate attempt to bring Soviet findings into international scientific discourse, though it would be many years before Western scientists began to engage seriously with the underlying research.

Brekhman continued working in the field until his death in 1994. His career spanned essentially the entire period of organized Russian adaptogen research, from the early definitions of the 1950s through the post-Soviet collapse. He is regarded as the founding father of adaptogen science in a way that has no real parallel in Western pharmacology.

★★★★★ 4.8 · 1,247 reviews

The Adaptogens Your Nervous System Has Been Missing.

Ashwagandha, rhodiola, and phosphatidylserine — clinically-studied ingredients that support healthy cortisol rhythms.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

The Key Plants: Which Herbs Did Soviet Scientists Study?

Soviet adaptogen development was not focused on a single plant. Over several decades of organized research, Soviet scientists investigated a range of botanical substances, primarily drawn from the flora of Siberia, the Soviet Far East, and Central Asia. Understanding which plants were studied — and what the evidence base looked like for each — is essential for evaluating the scientific legacy of this period.

Eleutherococcus Senticosus (Siberian Ginseng)

This was the flagship Soviet adaptogen and the most extensively studied plant in the entire program. Eleutherococcus senticosus — also marketed in the West as Siberian ginseng, though it is not a true ginseng — is a shrub native to the Ussuri region of the Soviet Far East, northeastern China, Japan, and Korea.

Brekhman's choice of Eleutherococcus as his primary research subject shaped the field for generations. The plant entered the Soviet pharmacopeia in 1962, following years of experimental work by Brekhman and his colleagues — a landmark in adaptogen scientific history and a formal institutional recognition of the research program's results. A 2025 comprehensive review on Eleutherococcus root summarized this historical Soviet research base and specifically noted this 1962 pharmacopeia listing as a defining moment in the plant's official recognition.

One review identified 46 Soviet studies on Eleutherococcus senticosus published between 1962 and 1986 — a substantial body of literature that has proven challenging for Western scientists to fully evaluate because much of it was published only in Russian. A 2025 Eleutherococcus review citing a 2021 Russian-literature review covering these 46 studies reinforced how significant this archival clinical record remains for contemporary researchers trying to understand the scope of Soviet-era work.

Rhodiola Rosea (Golden Root)

Rhodiola rosea, known in indigenous Siberian tradition as "golden root," was another major focus of Soviet adaptogen research. Growing primarily in alpine regions of Siberia, the Caucasus, and Scandinavia, Rhodiola had a long history of use among indigenous populations before Soviet scientists began formal study.

Soviet research on Rhodiola explored its effects on physical and mental performance under stress, its influence on neurotransmitter systems, and its potential for reducing fatigue. The plant received significant attention from Soviet military and defense researchers because of its effects on cognitive function under conditions of sleep deprivation and extreme physical stress — conditions directly relevant to military performance.

Rhodiola has arguably achieved the most successful transition into mainstream Western clinical research of any Soviet adaptogen. Modern randomized controlled trials have produced more robust evidence for Rhodiola than for most other adaptogens, which has helped to partially validate the Soviet-era claims, though the mechanisms are still being worked out.

Schisandra Chinensis (Five-Flavor Berry)

Schisandra chinensis — the five-flavor berry or Wu Wei Zi of Chinese medicine — was another plant that received extensive Soviet attention. Used for centuries in traditional Chinese and indigenous Siberian medicine as a tonic and general strengthener, Schisandra was studied by Soviet scientists for its effects on physical performance, liver function, and sensory acuity.

Soviet research on Schisandra was notable for including studies of its effects on night vision — a specific military interest — and on the performance of fine motor tasks under stress. Schisandra was reportedly used by Soviet pilots and was included in at least some of the Soviet defense-related research programs of the 1960s and 1970s.

Panax Ginseng

Although Panax ginseng (Asian or Korean ginseng) is most strongly associated with Chinese and Korean traditional medicine, Soviet scientists also conducted research on it. However, because true ginseng was expensive and not native to Soviet territory, it received less intensive investigation than the more regionally available alternatives. Soviet research on Panax ginseng nevertheless contributed to the broader adaptogen literature and helped establish comparative frameworks for understanding how different plants might produce similar adaptive effects.

Rhaponticum Carthamoides (Maral Root / Leuzea)

Less well-known in the West, Rhaponticum carthamoides was studied in the Soviet Union primarily for its effects on physical performance and muscle recovery. Soviet research suggested it had anabolic properties, making it of particular interest to sports scientists and military performance researchers. It remains less familiar to Western consumers than the other major Soviet adaptogens.

Aralia Mandshurica and Other Secondary Subjects

Soviet researchers also investigated Aralia mandshurica, Acanthopanax species, and various other plants from the Araliaceae family (the same botanical family as Panax ginseng and Eleutherococcus). These secondary subjects received less attention than the major adaptogens but contributed to the broader effort to identify and characterize adaptive botanical substances.

Soviet Military and Defense Applications of Adaptogens

The adaptogen military research dimension of Soviet science is perhaps the most dramatic and, in many ways, the most historically significant aspect of the entire program. Understanding why the Soviet state invested so heavily in adaptogen research requires understanding the Cold War security context in which the science was conducted.

Soviet military and defense interest in performance-enhancing substances was not a peripheral concern — it was a central driver of funding, institutional development, and research priorities throughout the post-war period. Soviet military planners were deeply concerned with the performance capacity of soldiers under conditions of extreme stress: extreme cold in Siberia and the Arctic, extreme physical exertion, sleep deprivation, high-altitude operations, radiation exposure following nuclear events, and the psychological stresses of combat and extended military service.

Synthetic stimulants had obvious limitations: they caused dependency, they produced performance crashes after the initial effect, they could not be used continuously without causing health damage, and many of them were controlled substances with complex supply chain implications. An effective, nontoxic, natural substance that could broadly enhance resistance to stress without these drawbacks would be, from a military standpoint, extraordinarily valuable.

This is the context in which adaptogen military research received substantial Soviet state funding from the late 1950s onward. Soviet-era programs in the 1970s reportedly tested cadets using Eleutherococcus, Schisandra, and Rhodiola in defense-related research — testing protocols that were designed to simulate military operational stress and evaluate whether adaptogen supplementation could measurably improve performance and resilience.

The Soviet military research program was conducted under conditions of secrecy that make it difficult to fully evaluate from the outside. Much of the military-oriented research was not published in scientific journals — it was classified and circulated only through internal channels. Some of this material has become more accessible since the collapse of the Soviet Union, but a significant portion remains either classified or simply unavailable in accessible archives.

What is clear from the historical record is that the Soviet military establishment took adaptogen research seriously. The fact that Eleutherococcus entered the official Soviet pharmacopeia in 1962 — just as the Cold War was reaching some of its highest tensions — suggests that institutional validation was proceeding on a timeline consistent with active official interest.

The military dimension also extended to research on radiation protection. Following the development of Soviet nuclear weapons and the growing awareness of radiation as a military threat, Soviet scientists investigated whether adaptogens could help protect against radiation damage. Some studies suggested that Eleutherococcus and other adaptogens could mitigate certain effects of radiation exposure in animal models. This line of research would later become practically relevant following the Chernobyl disaster in 1986, when adaptogens were reportedly distributed to workers and emergency responders involved in the cleanup.

Athletes, Cosmonauts, and Cold War Performance Enhancement

Beyond the military, Soviet adaptogen research had two other major application areas that shaped both the research program and its eventual legacy: elite athletic performance and the Soviet space program.

Soviet Athletes and the Adaptogen Advantage

The Soviet Union's remarkable run of athletic success during the Cold War era — particularly in the Olympics from the 1950s onward — has been extensively documented, and much of the retrospective discussion has focused on doping, particularly with anabolic steroids. But alongside the doping programs, Soviet sports scientists were also deeply involved in adaptogen research, and adaptogens were incorporated into the training and preparation protocols of Soviet athletes.

As National Geographic has documented in its coverage of this history, Soviet performance researchers were studying natural plant substances as performance enhancers long before the doping scandals that would later overshadow the era's athletic achievements. This is an important nuance: adaptogens occupied a different conceptual and regulatory category from anabolic steroids. They were not considered doping agents. They were considered nutritional or pharmacological supports for normal physiological function.

Soviet athletic training programs that incorporated adaptogens typically used them as part of a broader periodization and recovery strategy, not as acute performance boosters on competition day. The theory was that regular use of Eleutherococcus, Schisandra, or Rhodiola during training would enhance recovery, reduce training-related fatigue, support immune function during periods of heavy training load, and help athletes adapt more effectively to progressive training stress.

Soviet sports science institutions — particularly those working with Olympic sports federations — conducted studies on adaptogen use in athletes that formed part of the broader clinical evidence base. Some of these studies compared adaptogen-supplemented training groups with control groups on measures of recovery, endurance capacity, and training adaptation. The quality of these studies varied considerably, but they represented a genuine attempt to test the practical application of adaptogen theory in elite sport.

The Soviet Space Program

Perhaps the most striking application of Soviet adaptogen research was in the space program. Soviet cosmonauts faced physiological challenges that in many ways represented the extreme end of the stress spectrum that adaptogen theory was designed to address: microgravity-induced muscle and bone loss, circadian rhythm disruption, radiation exposure, psychological isolation, and the physiological stresses of launch and reentry.

Soviet space medicine researchers investigated adaptogens as potential countermeasures for some of these challenges. The exact scope of adaptogen use in the cosmonaut program is not fully documented in publicly available literature, but it is known that Soviet space medicine was closely connected to the adaptogen research program and that substances like Eleutherococcus were considered for use in supporting cosmonaut health and performance.

The space program connection gave Soviet adaptogen research a particular prestige within the Soviet scientific establishment. If these substances were considered good enough for cosmonauts — the heroes of Soviet technological achievement — they carried a certain institutional authority that supported continued funding and research.

How Much Evidence Actually Existed? The Soviet Clinical Record

One of the most common questions about Soviet adaptogen research concerns the actual scale and quality of the clinical evidence that was generated. The answer is more complicated than either adaptogen enthusiasts or skeptics typically acknowledge.

On the question of quantity, the numbers are genuinely impressive. A major review reported more than 1,000 pharmacological and clinical studies on adaptogens published in Russia up to 1982 — and that figure represents only the studies that were published in accessible scientific literature, not the classified military research or purely internal institutional reports. A 2026 article on the history of adaptogenesis went further, claiming more than 4,000 Russian clinical studies between 1960 and 1990. Even if that figure is somewhat inflated or includes a broader category of studies than strict clinical trials, it points to an extraordinary volume of scientific activity.

These numbers need context. Soviet science during this period was, in general, prolific. The Soviet state invested heavily in scientific research across all domains, and publication was encouraged, sometimes regardless of the quality or rigor of the underlying work. The Soviet scientific publication system operated under different norms than Western peer review, with different standards for what counted as publishable evidence.

On the question of quality, the picture is more mixed. Some of the Soviet adaptogen studies — particularly those conducted by Brekhman's group in Vladivostok and published in international journals — meet reasonably modern standards for experimental design. Many others, particularly those published only in Russian in internal or low-circulation journals, fall short by contemporary standards in important ways.

Common methodological concerns in Soviet adaptogen research include:

• Small sample sizes that limit statistical power and increase the risk of false positive findings
• Inadequate blinding in studies where subjects and researchers both knew who was receiving active treatment
• Variable product quality and standardization — the Eleutherococcus or Rhodiola used in one study may not have been chemically equivalent to the preparation used in another
• Publication bias — there is no way to know how many negative or null findings were simply not published
• Ideological pressure — Soviet scientists working on state-funded projects had institutional incentives to produce positive results
• Limited independent replication — because much of the research was concentrated in a small number of Soviet institutions, independent replication of findings was limited

None of these concerns is unique to Soviet adaptogen research. They apply to a great deal of mid-twentieth-century pharmacological research from all countries. But they are particularly significant here because the Soviet research was conducted in relative isolation from the international scientific community, limiting the corrective mechanisms that peer review and independent replication can provide.

The fact that a 2021 Russian-literature review covering 46 Eleutherococcus studies from 1962 to 1986 was still being cited in 2025 reviews reflects both the enduring importance of this body of work and the ongoing challenge of integrating it into contemporary evidence standards.

Criticisms and Limitations of Soviet Adaptogen Research

A frank assessment of the adaptogen research history requires engaging seriously with the criticisms that have been leveled at Soviet-era work. These criticisms come from multiple directions and deserve careful consideration.

The Problem of Access and Translation

The most fundamental challenge facing anyone trying to evaluate Soviet adaptogen research is that a large proportion of it was published only in Russian, in journals with limited international circulation, and before the era of digital archives. The barrier of language and access means that Western scientists have never been able to fully evaluate the Soviet evidence base. What has been available in English represents a curated selection — primarily the work that Soviet scientists chose to present to international audiences or that was translated by Western researchers with specific interests.

This cuts both ways. It means that Western dismissals of Soviet adaptogen research are sometimes based on ignorance of the actual evidence. But it also means that enthusiastic claims about thousands of clinical studies often rest on a literature that has never been independently reviewed in full.

Reproducibility in Western Settings

When Western scientists began attempting to replicate Soviet adaptogen findings from the 1980s onward, the results were mixed. Some findings — particularly those related to Rhodiola rosea's effects on fatigue and cognitive performance — have replicated reasonably well in rigorous Western trials. Others have proven much harder to demonstrate.

The reproducibility challenges may reflect genuine differences in study quality between the original Soviet work and subsequent Western attempts. But they may also reflect real differences in the populations studied, the preparations used, the outcomes measured, or the duration of treatment. Soviet research often involved populations under genuine occupational or military stress — miners, soldiers, shift workers — while many Western trials have used relatively healthy volunteers under laboratory conditions.

The Ideology Problem

Soviet science during the Cold War period was not immune to ideological influence. The Lysenko affair — in which the state-endorsed pseudoscience of Trofim Lysenko suppressed legitimate genetics research for decades — demonstrated that Soviet scientific institutions could be seriously distorted by political pressures. While adaptogen research was not directly connected to Lysenkoism, it operated in the same institutional environment.

The Soviet state had powerful reasons to want adaptogen research to produce positive results. Positive results would support the case that Soviet science was producing unique and valuable contributions unavailable to the capitalist world. They would support the Soviet athletic program. They would support military readiness claims. Under these circumstances, it would be surprising if institutional pressures did not systematically push research results in a positive direction.

This does not mean the research was fraudulent. It means that the normal tendency toward publication bias and selective reporting was likely amplified by the specific ideological context of Soviet science.

The "Nonspecific" Problem

Some pharmacologists have questioned whether the concept of "nonspecific resistance" itself is scientifically coherent. A substance that affects everything might, from one perspective, be a remarkably versatile medicine. From another perspective, a claim that something helps with all forms of stress is difficult to test rigorously and impossible to falsify — which is a significant problem from the philosophy of science standpoint.

If an adaptogen is defined as something that increases nonspecific resistance, then showing that it has any effect on any stress-related parameter could be presented as evidence that it "works." This makes the adaptogen concept both very broadly supported (because there will almost always be some parameter that shows an effect) and very hard to evaluate (because the hypothesis is essentially unstestable as a whole).

From Soviet Laboratories to Western Markets: The Transition

The journey of Soviet adaptogen research into Western consumer markets is a story that unfolded gradually over several decades, driven by a combination of scientific interest, Cold War information exchange, and ultimately the commercial forces of the natural products industry.

The first significant Western exposure to Soviet adaptogen science came through academic channels in the 1960s and 1970s. Brekhman's 1969 paper in Annual Review of Pharmacology was an important early bridge, as were a small number of other publications that appeared in Western pharmacological literature during this period. Western scientists who read these papers were often skeptical — partly because the concept of nonspecific resistance seemed imprecise, and partly because the evidence base was difficult to access and evaluate.

The next significant stage came in the 1980s, when a small number of Western researchers began actively investigating Soviet adaptogen claims. Swedish scientists played a particularly important role in this transition, studying Rhodiola rosea and Eleutherococcus and publishing results in Western journals that gave the field a degree of international credibility.

The collapse of the Soviet Union in 1991 was a pivotal moment for the transition to Western markets. Soviet scientists who had worked on adaptogen research suddenly had the freedom and, in many cases, the economic motivation to engage with Western companies and markets. The natural products industry — already growing rapidly in the early 1990s — was receptive to the idea of scientifically documented traditional plant medicines, and adaptogens fit this profile perfectly.

The framing of adaptogens in Western markets was not primarily scientific. It was drawn from the adaptogen research history but translated into consumer language: "stress relief," "energy," "mental clarity," "immune support." These claims were technically consistent with some of the Soviet research findings, but they also represented a significant simplification and in some cases a misrepresentation of what the research had actually shown.

By the 2000s and especially the 2010s, adaptogens had become a significant category in the natural products industry, with dozens of products on the market featuring Ashwagandha (an Indian adaptogen that somewhat overlapped with the Soviet tradition), Rhodiola, Eleuthero, Schisandra, and other substances. The Soviet research history was frequently cited in marketing materials, but often in ways that misrepresented or exaggerated the actual evidence.

★★★★★ 4.8 · 1,247 reviews

See Why Athletes And Executives Take It Daily.

Adaptogen-based formula, third-party tested, made in the USA. Cancel subscription anytime.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

What Soviet-Era Findings Still Hold Up Today?

One of the most practically important questions about adaptogen scientific history is which Soviet-era findings have been supported by subsequent research using modern methods. The answer requires distinguishing between different plants and different claimed effects.

Rhodiola Rosea — Strongest Contemporary Support

Of all the Soviet adaptogens, Rhodiola rosea has the strongest contemporary evidence base. Multiple randomized controlled trials conducted in the 2000s and 2010s have found effects on fatigue, stress-related symptoms, and cognitive performance that are broadly consistent with Soviet-era claims. A 2012 systematic review published in Phytomedicine found that several rigorous trials supported Rhodiola's effects on physical and mental fatigue. The active compounds — rosavins and salidroside — have been identified and partially characterized.

This does not mean every Soviet claim about Rhodiola is validated. But it does mean that the core claim — that Rhodiola has measurable effects on stress response and fatigue — has survived the transition to modern clinical research better than most other adaptogens.

Eleutherococcus Senticosus — Moderate Support

The evidence for Eleutherococcus is more mixed. Some Western trials have found effects on immune function and endurance performance, while others have found no significant effect. A 2009 Cochrane review of Eleutherococcus found insufficient high-quality evidence to make firm conclusions. The recent 2025 comprehensive review on Eleutherococcus root continued to highlight the historical Soviet research base while noting the continued need for rigorous contemporary trials.

The gap between the extensive Soviet clinical record and the modest contemporary evidence base for Eleutherococcus illustrates the challenges of translating Soviet-era findings. It is possible that the Soviet studies detected real effects that modern trials have failed to detect due to differences in populations, preparations, or measurement methods. It is also possible that some Soviet findings were the product of publication bias and methodological limitations.

Schisandra — Limited Modern Data

Schisandra has received relatively less attention in modern clinical research compared to its prominence in Soviet studies. The available evidence suggests some activity — particularly on liver function and possibly on endurance performance — but the modern evidence base is thin and methodologically variable. Claims about night vision improvement, which featured in Soviet military research, have not been rigorously tested in modern settings.

Adaptogens and the Immune System

Soviet research placed considerable emphasis on adaptogen effects on immune function, particularly the enhancement of nonspecific immunity. Some contemporary research has supported immune-modulating effects for several adaptogens, particularly Eleutherococcus and Ashwagandha (the Indian adaptogen studied through a related but distinct tradition). However, the mechanisms are not fully understood, and the clinical relevance of these effects in healthy populations remains debated.

What Remains Unvalidated

Many specific Soviet claims remain unvalidated by modern research, not necessarily because they are wrong, but because they have not been adequately tested. The Soviet research on adaptogen effects on radiation exposure, on high-altitude performance, and on the recovery from toxic exposure represents areas where modern trials are sparse. Whether this reflects limitations of the Soviet research, difficulties in designing appropriate trials, or simply a lack of commercial incentive to fund research in these areas is unclear.

The Difference Between Soviet Science and Modern Supplement Marketing

Perhaps the most important distinction to understand for any contemporary consumer of adaptogen products is the significant gap between what Soviet adaptogen research actually claimed and what modern supplement marketing typically says.

Soviet scientists working in the adaptogen tradition were, at least in principle, operating within a scientific framework. Their claims were specific. Their subjects were often people under genuine occupational or military stress — workers in physically demanding environments, soldiers, athletes undergoing heavy training loads. The effects they were measuring — reduced incidence of illness, faster recovery from fatigue, maintenance of performance under stressful conditions — were relatively concrete and measurable, even if the measurements were not always rigorous.

Modern supplement marketing has taken the vocabulary of Soviet adaptogen science and applied it to a completely different context. The consumer being targeted is typically not a miner working twelve-hour shifts in Siberian winter conditions or a military cadet being tested in simulated combat stress. They are typically an office worker experiencing the ordinary stresses of modern life. Whether the effects documented in Soviet research with heavily stressed populations would translate to effects in this very different population is a question that the marketing simply does not address.

There is also the problem of preparation. Soviet research was conducted with specific preparations — extracts standardized in particular ways, used in specific doses, for specific durations. Modern adaptogen supplements vary enormously in the quality of the raw material, the extraction method, the concentration of active compounds, and the dose. A product labeled "Eleuthero root powder" that contains unstandardized dried root material at an arbitrary dose is not equivalent to the standardized fluid extracts used in Brekhman's studies, and there is no scientific basis for assuming they would have the same effects.

The adaptogen history gives modern products their scientific credibility narrative. The Soviet research history is invoked — sometimes accurately, sometimes not — to create the impression that these are not merely trendy wellness products but substances with a deep scientific foundation. Understanding that foundation in detail is the best tool consumers have for evaluating these claims critically.

Frequently Asked Questions

What is an adaptogen in the Soviet scientific tradition?

In the Soviet scientific tradition established by Nikolai Lazarev in 1958 and further developed by Israel Brekhman, an adaptogen is a pharmacological agent that increases nonspecific resistance to a broad range of stressors — physical, chemical, and biological — without causing significant toxicity or disrupting normal physiological function. The concept also included the idea of normalization: the substance should bring physiological parameters toward optimal homeostasis regardless of whether they were elevated or depressed. This is a more specific and demanding definition than the term is typically used in contemporary wellness marketing.

Who were Nikolai Lazarev and Israel Brekhman?

Nikolai Lazarev (1895–1974) was a Soviet pharmacologist and toxicologist who coined the term "adaptogen" in 1958 and introduced the foundational concept of nonspecific resistance. Israel Brekhman (1921–1994) was his student and the most prolific researcher in the field, working primarily at the Institute of Biologically Active Substances in Vladivostok. Brekhman conducted the foundational research on Eleutherococcus senticosus, refined the adaptogen definition, and brought the concept to international attention through publications in Western journals. Together, they are considered the founding fathers of adaptogen science.

Which plants were the main Soviet adaptogens?

The primary plants studied in Soviet adaptogen research were Eleutherococcus senticosus (Siberian ginseng), Rhodiola rosea (golden root), Schisandra chinensis (five-flavor berry), Panax ginseng (Asian ginseng), Rhaponticum carthamoides (maral root), and various species in the Araliaceae family. Eleutherococcus was the most extensively studied, entering the Soviet pharmacopeia in 1962 and becoming the signature Soviet adaptogen.

How much Soviet clinical evidence actually existed?

The scale of Soviet adaptogen research was substantial. A major review reported more than 1,000 pharmacological and clinical studies published in Russia up to 1982. A 2026 historical review claimed more than 4,000 Russian clinical studies between 1960 and 1990. For Eleutherococcus alone, a review identified 46 Soviet studies published between 1962 and 1986. However, the quality of this evidence varied significantly, and much of it was published only in Russian and has never been fully evaluated by Western scientists using contemporary methodological standards.

Were adaptogens used for athletes, soldiers, or cosmonauts?

Yes, in all three contexts. Soviet military research in the 1970s reportedly tested cadets using Eleutherococcus, Schisandra, and Rhodiola in defense-related programs. Soviet athletes incorporated adaptogens into training protocols, and adaptogen research was conducted by Soviet sports science institutions. The Soviet space program also explored adaptogens as potential supports for cosmonaut health and performance. Each of these applications was connected to the core scientific interest in substances that could enhance nonspecific resistance under conditions of genuine physiological stress.

What is the difference between Soviet adaptogen research and modern supplement marketing?

Soviet research involved specific, standardized preparations tested in populations under genuine occupational or military stress, measuring concrete physiological and performance outcomes. Modern supplement marketing applies the vocabulary of this research to very different products — often unstandardized, at unverified doses — marketed to populations experiencing ordinary modern stress rather than the extreme conditions studied in Soviet research. The marketing invokes the scientific history but rarely acknowledges the significant gap between the original research context and the contemporary consumer context.

Which Soviet findings are still considered credible today?

Rhodiola rosea has the strongest contemporary support, with multiple modern randomized controlled trials replicating aspects of Soviet claims about fatigue reduction and stress response. Eleutherococcus has some contemporary support, particularly for immune function, though evidence is more mixed. Schisandra has limited contemporary evidence. Many specific Soviet claims — particularly those relating to radiation protection, night vision, and extreme-environment performance — have not been adequately tested in modern research settings.

What are the main criticisms of adaptogen research quality?

Key criticisms include: small sample sizes, inadequate blinding, variable product standardization, probable publication bias, ideological pressure toward positive results in the Soviet institutional context, limited independent replication within the Soviet system, and the conceptual imprecision of "nonspecific resistance" as a testable hypothesis. Additionally, much of the literature is accessible only in Russian, making full independent evaluation difficult. These criticisms do not necessarily mean the research findings are wrong, but they do mean that the Soviet evidence base requires significant methodological qualification when applied to contemporary clinical decisions.

Conclusion

The history of Soviet adaptogen research is one of the twentieth century's most interesting and underappreciated stories in pharmacology. It began with genuine scientific curiosity and military necessity, developed into one of the most prolific botanical research programs in history, and ultimately escaped its Cold War origins to shape a multibillion-dollar global wellness industry.

At its core, the Soviet adaptogen program asked a genuinely important scientific question: can natural substances meaningfully enhance an organism's ability to resist a broad range of stresses? Seventy years of research have not produced a definitive answer to that question, but they have produced a substantial body of suggestive evidence, particularly for Rhodiola and to a lesser degree Eleutherococcus.

Understanding the adaptogen discovery story — the role of Lazarev's 1958 definition, Brekhman's decades of clinical investigation, the military programs of the 1960s and 1970s, the more than 1,000 published studies up to 1982, and the eventual transition into Western markets — is essential context for anyone trying to evaluate these substances critically today. The Soviet research was neither the pseudoscientific propaganda that Western skeptics sometimes claimed nor the definitive clinical proof that supplement marketers imply.

It was real science, conducted under difficult conditions, with genuine findings and genuine limitations, by scientists who were working at the intersection of legitimate pharmacological inquiry and Cold War institutional pressures. That complexity deserves to be acknowledged rather than flattened in either direction.

The most honest conclusion is that Soviet adaptogen science identified a genuinely interesting pharmacological territory, documented it imperfectly but substantially, and handed the contemporary world a research agenda that is still far from complete. The question the Soviet scientists asked is still worth asking. The methods they used were a starting point, not an ending point. And the commercial ecosystem that now sells adaptogens in every health food store in the world has a complicated relationship with the scientific tradition it claims to represent.

For consumers, practitioners, and researchers alike, engaging with the actual adaptogen science history — rather than the simplified version offered by marketing narratives or reflexive skepticism — is the most useful starting point for thinking clearly about what these substances might and might not do.

★★★★★ 4.8 · 1,247 reviews

Ready To Try Adaptogen-Based Cortisol Support?

Third-party tested. 60-day guarantee. Free shipping over $40. Ships in 24 hours.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

This article is intended for informational and educational purposes only. It does not constitute medical advice. Consult a qualified healthcare professional before using any supplement, particularly if you have existing health conditions or take medications.

References and Sources:

1. National Geographic — Long Before Doping Scandals, Russians Were Studying Performance Enhancement. https://www.nationalgeographic.com/culture/article/long-before-doping-scandals--russians-were-studying-performance-
2. PMC Review of Adaptogen History (PMC7756641). https://pmc.ncbi.nlm.nih.gov/articles/PMC7756641/
3. Science News — Warming to a Cold War Herb. https://www.sciencenews.org/article/warming-cold-war-herb
4. Lazarev NV (1958). Pharmacological classification of substances as stimulants of nonspecific resistance. Proceedings of the USSR Academy of Medical Sciences.
5. Brekhman II, Dardymov IV (1969). New substances of plant origin which increase nonspecific resistance. Annual Review of Pharmacology, 9, 419–430.
6. 2021 Russian-literature review covering 46 Eleutherococcus senticosus studies (1962–1986), as cited in 2025 comprehensive Eleutherococcus review.
7. 2025 comprehensive review on Eleutherococcus root — historical Soviet research base and 1962 Soviet pharmacopeia listing.
8. 2026 article on history of adaptogenesis — Soviet-origin timeline and Russian clinical studies 1960–1990.